Chemically induced differentiation of murine erythroleukemia cells is a multistep process involving a precommitment period in which exposure to inducer leads to cells that are irreversibly committed to terminal differentiation. Certain changes in the expression of cellular proto-oncogenes are an important feature of the precommitment phase. We have identified two HI histone genes that are rapidly induced during this period. Unlike most histone genes, these two HI genes encode polyadenylated mRNAs with long 3' untranslated regions. To investigate the relationship between induction of the HI mRNAs and changes in proto-oncogene expression, we studied two independent series of mouse erythroleukemia cell lines that are inhibited from differentiating because of deregulated expression of transfected copies of c-inyc or c-myb. The results showed that induction of the HI mRNAs was negatively regulated by c-myc. The two Hi histone genes are among the first examples of specific cellular genes that are regulated by c-myc. The timing of their induction suggests that they may play an important role in achieving commitment to terminal differentiation.
The murine erythroleukemia (MEL) cell system has provided a useful cell culture model for studying the regulation of erythroid development. These cells also offer the opportunity to investigate the molecular events occurring when tumor cells reinitiate a terminal differentiation program. MEL cells are transformed erythroid precursors that are blocked from completing the terminal stages of erythroid differentiation (16, 34) . Treatment of these cells with a variety of low-molecular-weight compounds, notably dimethyl sulfoxide (DMSO) and hexamethylene bisacetamide (HMBA), causes them to reenter a differentiation program culminating after 4 to 5 days in terminal cell divisions and the accumulation of hemoglobin and other erythrocyte-specific proteins (34) .
The continuous presence of an inducing agent is not required for terminal differentiation of MEL cells. After about 24 h of inducer treatment, a substantial fraction of the cells become irreversibly committed to terminal differentiation such that they can complete differentiation in the absence of inducer (15, 18) . Whereas there are a number of specific markers characteristic of the terminally differentiated cells, only a few changes in cellular activities have been described to occur during the precommitment period. There are very rapid changes in the transport of ions and other small molecules (5, 14, 29, 33) and in phosphatidylinositol turnover (13) soon after addition of inducer. There also are rapid changes during the precommitment period in the expression of certain cellular proto-oncogenes (28, 41) . For example, the amount of c-myc mRNA drops to a very low level within 1 h after addition of inducer. It is maintained at this low level during most of the precommitment period but is reexpressed to the original level just before cells begin to commit to terminal differentiation. The level of mRNA then declines again as cells undergo differentiation (28) . The mRNA for c-mvb exhibits very similar fluctuations (7. 41) . Several groups of investigators have attempted to evaluate the significance of these changes in c-mnyc and c-,nvb gene expression by transfecting MEL cells with expression vectors containing these genes driven by heterologous promoters (7, 8, 10, 26. 40) . The results have shown that these changes in expression are important for terminal differentiation of MEL cells. In particular, constitutive expression of exogenously introduced c-mv'c or c-mvb causes a marked inhibition of terminal differentiation.
The mechanisms by which these two proto-oncogenes affect differentiation of MEL cells are not known, in large part because the cellular targets of their protein products remain to be elucidated. We Deregulated c-myb transfectants, clones 87C, 89A, and 91A (7), were a generous gift from Edward V. Prochownik. They were grown in Dulbecco modified Eagle medium with 10% fetal bovine serum. Differentiation of all transfected cell lines was induced as described above except that the growth medium contained 1.8% (voUvol) DMSO. Benzidine-reactive cells were scored as described previously (4) .
Isolation of Hi cDNA clones. Hi cDNA sequences were isolated from a cDNA library in bacteriophage lambda gt1O. The (42) . A 10-p,g sample of RNA was dissolved in 50 mM boric acid-5 mM sodium borate-10 mM sodium sulfate-0.1 mM EDTA-50% formamide-6% formaldehyde, heated at 65°C for 5 min, and fractionated by electrophoresis in 1.2% agarose gels containing 3% formaldehyde. RNA was transferred to nitrocellulose papers by the method of Thomas (44) . Unless otherwise indicated, the blots were hybridized with nick-translated DNA probes by incubation at 45°C in a solution containing 50% formamide, 5x SSC, 50 mM sodium phosphate (pH 6.8), 5x Denhardt solution, 0.1% sodium dodecyl sulfate, and 60 pLg of denatured salmon sperm DNA per ml, followed by washing at 550C with 0.1x SSC-0.1% sodium dodecyl sulfate.
RESULTS
Isolation of cDNA clones of inducible, polyadenylated Hi histone mRNAs. To evaluate the changes in HI histone mRNA levels during MEL cell differentiation and to determine whether any distinct Hi histone mRNAs were induced during differentiation, we used a DNA probe derived from a human HI histone gene (25) . The (15, 18) . Most cells are committed by 48 h of inducer treatment, and globin mRNAs, which begin to accumulate shortly after 24 h, continue to accumulate until about 96 h (17) . If the inducer is removed during the precommitment period, before 24 h nearly all cells retain the unlimited proliferative capacity exhibited by untreated cells.
Levels of the major nonadenylated Hi histone mRNAs were quite constant in MEL cells during the first 24 h of HMBA treatment (Fig. 1A) . In contrast, the polyadenylated mRNAs for H1-var.1 and Hi°were very strongly induced during this precommitment period (Fig. 3) ing a maximum at 24 h and gradually declining thereafter as the cells underwent differentiation.
We have described previously the biphasic change in c-myc mRNA levels that occurs during the precommitment period when MEL cells are treated with inducing agents (27, 28) . The amount of c-myc mRNA was greatly reduced within 1 h of HMBA treatment (Fig. 3C) (8) . Both pairs of lines exhibited high levels of expression of the exogenous c-mnc transcripts after induction with DMSO ( Fig. 4h and 4i) , whereas endogenous c-myc transcripts undergo a biphasic change in expression similar to that shown in Fig. 3 (8, 10 (Fig. 4g) . 56 (panels b, e, and h), and 60 (panels c, f, and i) (10), were grown in the presence of 1.8% DMSO. At the times indicated, total cellular RNA was prepared and analyzed by blot hybridization with the following electroeluted DNA fragments: an EcoRI insert from pcMH1-var.1 (panels a through c), an EcoRI insert from pcMHl°(panels d through f), and a 1.4-kb Xho fragment from pcmyc54 (43) (panels g through i). After 5 days of DMSO treatment, clone 57 produced 85% benzidine-positive cells, whereas clones 56 and 60 produced less than 1% positive cells.
was strongly induced during the first 24 h of DMSO treatment. Induction of H1-var.1 mRNA was nearly completely inhibited in the two transfectant cell lines (clones 56 and 60) expressing high levels of exogenous human c-myc (Fig. 4b  and c) . The presence of the cross-hybridizing, nonadenylated Hi mRNA band provided an internal control for the amount of RNA loaded and the efficiency of transfer and hybridization. Similar results were obtained with lines expressing exogenous simian virus 40-promoted mouse c-myc (data not shown). The induction of Hio mRNA also was sensitive to inhibition by an exogenous c-myc gene (Fig. 4d through f). Hio mRNA was strongly induced in clone 57, which differentiated normally, whereas its induction was drastically reduced in the transfectant lines expressing exogenous c-myc genes. These results indicate that the induction of both polyadenylated Hi mRNAs, which normally occurs during the precommitment period, does not take place when an exogenous c-myc gene is expressed at high levels during this early period.
Specificity of the effect of c-myc on polyadenylated Hi mRNA induction. The deregulated c-myc MEL cell transfectants used in this study do not differentiate, as judged by their failure to accumulate hemoglobin and withdraw from the cell cycle (8) . Although these events occur late in the MEL cell differentiation program, whereas the induction of the polyadenylated Hi mRNAs occurs much earlier, it is possible that the effect of deregulated c-myc expression on Hi mRNA induction is due to a general effect on all aspects exhibited by differentiating MEL cells.
Relatively few early changes in gene expression after inducer treatment have been described. However, in addition to the early biphasic change in c-myc mRNA and the induction of polyadenylated Hi mRNAs described here, there are changes in the mRNA levels for several other nuclear proto-oncogenes during the first 24 h of MEL cell differentiation. Dmitrovsky et al. (10) have studied the early decline and reexpression of endogenous c-myb and c-myc transcripts in the deregulated c-myc transfectants (clones 56 and 60) used in our study. These authors found that the early changes in the two endogenous proto-oncogene mRNAs were not affected by the deregulated expression of the transfected human c-myc gene. Thus, two types of early changes in mRNA levels characteristic of inducer-treated MEL cells are unaffected by deregulated c-myc expression, whereas induction of the polyadenylated Hi mRNAs is markedly inhibited.
DMSO induction of MEL cell differentiation also can be inhibited by deregulated expression of a c-myb gene (7) . To determine whether the effect of c-myc on polyadenylated Hi mRNA induction is specific, we studied expression of the mRNAs in several MEL cell lines that had been transfected with a full-length human c-myb cDNA driven by simian virus 40 transcription signals. These lines produced high levels of human c-myb transcripts after DMSO treatment, whereas endogenous mouse c-myb expression undergoes an early biphasic change similar to that seen in untransfected MEL cells (7) . Deregulated expression of the human c-myb cDNA led to a marked inhibition in the production of hemoglobinaccumulating cells after DMSO treatment. Results of expression studies of the polyadenylated Hi mRNAs in these c-myb-inhibited lines showed that despite the failure of these lines to undergo differentiation, the pattern of induction of (7), were grown in the presence of 1.8% DMSO. At the times indicated, total cellular RNA was prepared and analyzed by blot hybridization with the following electroeluted DNA fragments: an EcoRI insert from pcMH1-var.1 (panels A and B), an EcoRI insert from pcMH1°(panels C and D), and a 1.4 kb Xho fragment from pcmyc54 (43) (panels E and F). After 5 days of DMSO treatment, both clones produced about 5% benzidine-positive cells.
the H1-var.1 mRNA was retained (Fig. 5) . The mRNA was strongly induced after 8 h of DMSO treatment (Fig. 5A and 5B), similar to the induction seen in wild-type MEL cells treated with HMBA (Fig. 3) . The early induction of Hi°m RNA also was observed in these c-myb-transfected lines ( Fig. 5C and D) . However, the pattern observed in these transfected lines after the initial induction was different from that observed in untransfected MEL cells. Whereas in MEL cells Hi0 mRNA was maintained at high levels until the final stages of differentiation (Fig. 3) , the Hi0 mRNA induced in the deregulated c-myb transfectants declined after 8 h. Thus, although deregulated c-myb expression did not affect the early induction of Hi0 mRNA, it did appear to have an effect on the maintenance of Hi0 mRNA levels at later times. As reported previously (7) and shown in Fig. SE and F , the early biphasic change in c-myc mRNA levels was not altered in these transfected cells.
To make a direct, quantitative comparison of the expression patterns of the polyadenylated Hi mRNAs in the two types of transfectants, we prepared single RNA blots with RNAs from both deregulated c-myc and deregulated c-myb transfectants as well as from a control transfectant line not expressing an exogenous oncogene. After hybridization with either the H1-var.1 or the Hi0 probe, the resulting bands in the autoradiogram were quantitated by densitometry. In comparison with the control transfectant line and the c-myb transfectant, the deregulated c-myc transfectant exhibited a 10-to 20-fold reduction in expression of the Hl-var.1 mRNA and a 5-to 10-fold reduction in expression of the Hi0 mRNA (Fig. 6) . These results indicate that the inhibition of polyadenylated Hi mRNA induction observed in deregulated c-myc transfectants is specific. This inhibition did not occur when expression of another nuclear proto-oncogene, c-myb, (30) . Conversely, H1" accumulates in cultured cells when growth has been arrested (9, 37, 39) and in adult tissues containing a high proportion of nondividing cells (36) . It also is present in the chromatin of certain terminally differentiated cells, including MEL cells (12, 22, 35) . Very little is known about the significance of these changes in Hi subtypes for the functional state of the cell. Hi histones are involved in the formation of higher-order chromatin structures. Since changes in chromatin structure and transcriptional activity occur extensively during development and cell differentiation, specific changes in the Hi subtypes in chromatin could play an important role in these processes. However, direct proof for such a role is lacking.
The results reported here suggest that the MEL cell system may provide a useful model for investigating the role of HI subtypes in a specific differentiation process. The MEL cell differentiation program is quite well defined at the temporal level. It consists of a precommitment period lasting about 24 h. During this period, the cells undergo certain changes which cause them to become irreversibly committed to terminal differentiation. Once a cell is committed, it no longer requires the presence of inducer to execute the differentiation process. Differentiation, occurring between 24 and 96 h, involves the accumulation of globin mRNA, the synthesis of hemoglobin and other erythrocyte-specific proteins, and the cessation of cell division. It appears that induction of the polyadenylated Hi mRNAs is not simply a consequence of the differentiation process (Fig. 3) . Instead, the kinetics of induction suggests that these mRNAs may be induced as part of the events leading to cell commitment. Induction of both mRNAs was detected as early as 1 h after inducer was added. Moreover, induction did not depend on the differentiation process, since the early induction of the two mRNAs also was observed in deregulated c-rnyb transfectants that failed to differentiate. It Recent progress in understanding some of the events required for MEL cell differentiation has come with the recognition that expression of certain cellular proto-oncogenes undergoes complex changes both before and after commitment of the cells to terminal differentiation (28, 41) . Transfection studies using vectors that direct expression of c-mv c and c-m!,b have shown that constitutive expression of either of these two proto-oncogenes blocks MEL cell differentiation (7, 8, 10, 26, 40) . However differentiation is a complex, multistep process, and it is not known whether these two proto-oncogenes affect differentiation by interacting with the same or different cellular targets. The time of their action in the differentiation program also is not known. After treatment of MEL cells with an inducer, the mRNA levels from both proto-oncogenes exhibit a rapid decline, but they are reexpressed at intermediate times and then decline again as the cells differentiate (7, 28) . A recent study suggests that for c-m!vc, the later but not the earlier decline is required for differentiation (24) . Our results suggest that both the targets and the timing of the effect of the two proto-oncogenes in MEL cells may be different. Inhibition of the early induction of the polyadenylated Hi mRNAs was observed in deregulated c-mvc but not c-mnyb transfectants. Thus, with induction of the Hi mRNAs used as a more specific measure, it seems that the effects of the two protooncogenes are different. Moreover, it is clear from our observations that deregulated expression of c-mvc does affect early events in the MEL cell differentiation program. We also found an effect of deregulated c-rnvb expression on the maintenance of H1" mRNA levels after the initial induction. On the basis of this observation, we would tentatively suggest that the timing of the c-mvb effect on differentiation may be later than that of c-mnvc.
Determining the mechanism by which the c-mvc protooncogene exerts an effect on cell division is of fundamental importance to understanding the role of c-mnve in control of normal and abnormal growth. A crucial step in achieving this goal is the identification of specific cellular genes that are regulated by c-mvc and the demonstration that such genes participate in the control of cell division. The c-mvc protein is localized in the nucleus and appears to have DNA-binding activity (1, 2, 11, 19, 38) . although specific binding has yet to be demonstrated. These observations have led to the suggestion that the c-mvy protein may be a regulator of transcription. Support for this idea has come from experiments demonstrating that c-mvc can stimulate expression of Drosophlila and human heat shock protein genes in cotransfection assays (20, 23) . These studies also showed that c-nvc can inhibit expression from the mouse metallothionein I gene, which indicates that it also can exert negative control on gene expression. It seems likely that the heat shock protein and metallothionein genes are involved in cellular responses to stress conditions rather than in control of cell division.
The synthesis of HP, on the other hand, is correlated with growth arrest (9, 37, 39) . Furthermore, we have found that both Hl-var.1 and H1" transcripts are induced in mouse fibroblasts arrested by serum starvation and that these mRNAs disappear rapidly from the cells when growth is stimulated by restoration of serum levels (unpublished observations). Previous work has shown that c-mnvc mRNA MOL. CELL. BIOL.
on July 7, 2017 by guest http://mcb.asm.org/ Downloaded from levels are low in serum-starved fibroblasts and that they rise dufing serum stimulation (6, 21) . We also found that the levels of both polyadenylated HI transcripts are inversely correlated with c-rnvc mRNA levels in a variety of fetal and adult mouse tissues (unpublished observations). Thus, the inverse relationship between c-mnvc expression and expression of the two Hi histone genes appears to be quite general. These studies with c-mnc transfectants have allowed us to demonstrate directly that c-ive is involved in controlling expression of both Hi genes. These two Hi histone genes are promising candidates for studies of the mechanisms of specific gene regulation by c-mA,c.
